cll whiteboard #1: introduction & mechanisms of action of bcr signaling inhibitors
Published 6 years ago • 3.5K plays • Length 6:30Download video MP4
Download video MP3
Similar videos
-
22:23
the bcr signaling pathway in cll
-
2:22
cll whiteboard #3: mechanisms of action of anti-apoptotic bcl2 inhibitors
-
20:59
targeted inhibition of signal molecules as novel therapy for cll
-
29:14
ibrutinib resistance-mechanisms and options in cll
-
2:20
cll whiteboard #2: mechanisms of action of anti-cd20 agents
-
35:31
cll: btk inhibitors in hematologic oncology pathways - pathway-guided choices
-
2:14
targeting b-cell receptor signaling for anticancer therapy
-
26:32
bhcs2002/2019 basic lab skills
-
11:59
an introduction to on-section clem
-
4:00
oncogenic activation receptor tyrosine kinases
-
8:00
chronic myeloid leukemia etiology. mechanism of tyrosine kinase pathway how bcr-abl1 is formed
-
3:12
hcc whiteboard #3: the management of adverse events of tyrosine kinase inhibitors
-
25:09
cll: long-term updates on ibrutinib and idelalisib
-
49:01
chronic lymphocytic leukemia: case discussions
-
28:25
tkis, apoptotic enhancers, and other small molecules in the pipeline
-
18:36
update on pi3k inhibitors for cll: idelalisib, copanlisib, duvelisib, and umbralisib
-
32:12
keynote lecture 2: understanding the relevant immune mechanisms in gi cancer
-
19:19
addressing unmet needs in wm: strategies for treatment selection